← Eichor
Condition: Synchronous Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Synchronous Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
NA · 1 location(s) · Laval University · NCT06349278
Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer
Phase N/A · 1 location(s) · Affidea Nu-med Center of Oncological DIagnostics and Therapy · NCT07686016
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT06850103
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Sync
Phase 3 · 5 location(s) · David Palma · NCT05717166
Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC(ARMOR2501)
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06924398
FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07467434
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Phase 3 · 1 location(s) · Roswell Park Cancer Institute · NCT06563388
Health-Related Quality of Life and Metabolic Outcomes in PCOS
NA · 1 location(s) · The Cleveland Clinic · NCT07571915
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
NA · 3 location(s) · Yonsei University · NCT05753839
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
Phase 3 · 26 location(s) · UNICANCER · NCT04747054
Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases
NA · 1 location(s) · Oslo University Hospital · NCT06200831
Stereotactic Magnetic Resonance Guided Radiation Therapy
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT04115254
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
NA · 13 location(s) · Imperial College London · NCT02246634
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05775146
Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06354218
Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT02886104
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
NA · 6 location(s) · Niels Fristrup · NCT03977571
Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Canc
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07505173
Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06002789
Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06787625
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
Phase 2/Phase 3 · 1 location(s) · Second Affiliated Hospital of Nanchang University · NCT07131319
Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship
NA · 1 location(s) · Massachusetts General Hospital · NCT06807086
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.